Description

4-(6-(3,5-Dimethyl-1H-Pyrazol-1-Yl)-[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Butanoic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new drug candidates.
• Kinase Inhibitor Research: Serves as a core scaffold for the design and synthesis of potential kinase inhibitors for oncology and inflammatory diseases.
• Medicinal Chemistry: Used in structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Biochemical Research: Employed as a tool compound in biochemical assays and target validation studies.
• Custom Synthesis: A starting material for the contract manufacturing of specialized APIs and novel chemical entities (NCEs).
• Academic Research: Utilized in university and institutional labs for exploratory synthetic chemistry and pharmacology projects.

Basic Information

Product Name	4-(6-(3,5-Dimethyl-1H-Pyrazol-1-Yl)-[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Butanoic Acid
CAS No.	1279219-49-6
Molecular Formula	C16H18N6O2
Molecular Weight	326.36 g/mol
Synonyms	4-[6-(3,5-Dimethyl-1H-pyrazol-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]butanoic acid; 4-(6-(3,5-Dimethyl-1H-pyrazol-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)butyric acid; Butanoic acid, 4-[6-(3,5-dimethyl-1H-pyrazol-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-; CAS 1279219-49-6
EINECS	Contact for details

Quality Control

Our 4-(6-(3,5-Dimethyl-1H-Pyrazol-1-Yl)-[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Butanoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and NMR/LC-MS for structural confirmation, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container should be kept in a desiccated environment to prevent moisture absorption. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.